Table: Brightpath Biotherapeutics - 6-MTH parent results

BrightPath Biotherapeutics Co

08/11/2019 06:00

Nov 8 (Reuters)- 
             Brightpath Biotherapeutics Co., Ltd. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to  
                Sep 30, 2019        Sep 30, 2018      Mar 31, 2020  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             1 mln                                 4 mln     
                                                       (-97.4 pct)  
  Operating     loss 843 mln                            loss 2.42   
  Recurring     loss 841 mln                            loss 2.42   
  Net           loss 837 mln                            loss 2.44   
  EPS          loss 19.94 yen                        loss 58.03 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Brightpath Biotherapeutics Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T